Grand
Angels

Vanderwel MVCA Award Video  

BlueWillow Biologics Awarded Grant for Chlamydia Vaccine Development – 9/26/2018 BlueWillow Biologics® has been awarded a NIH Small Business Innovation Research (SBIR) grant for the development of an intranasal NanoVax® vaccine for the prevention of chlamydia. There are more than 131 million new chlamydia infections worldwide each year and no approved vaccine currently exists to […]

EPA Approves Spear®-Lep Bioinsecticide for Use on Outdoor Crops – Vestaron Press Release 9/20/18 The EPA has approved Vestaron’s second peptide-based product for use on outdoor crops. These products are designed to be non-toxic to mammals, birds, fish, honeybees and other beneficial insects.

Grand Angels targets up to $25 million for new VC fund – MiBiz 8/18/18 Investment firm Grand Angels plans to launch its third venture capital fund, MiBiz has learned. Grand Angels Venture Fund III LLC seeks to raise $15 million to $25 million that builds off of two prior, smaller venture capital funds at the […]

VNN Launches Pro Shop With Amazon Business – Press Release, Aug. 14, 2018

New Bioinsecticide Gets OK for Use on Greenhouse Crops – Greenhouse Grower, July 18, 2018

Tetra Discovery Partners Initiates Phase 2 Trial of BPN14770 in Fragile X Syndrome – Business Wire, July 10, 2018

Agtech startup raising $12M to commercialize biopesticide – MiBiz, July 7, 2018

Gemcabene Meets Primary Endpoint in INDIGO-1 Study of Severe Hypertriglyceridemia (SHTG) Patients – Gemphire Therapeutics Press Release, June 29, 2018

Vestaron Appoints Anna Rath as Chief Executive Officer – Vestaron Press Release, June 20, 2018